UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

Breast cancer research and treatment, 2017-08, Vol.164 (3), p.649-658

2017

Volltextzugriff (PDF)

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)

NPJ precision oncology, 2024-03, Vol.8 (1), p.67-67, Article 67

2024

Volltextzugriff (PDF)

Improved Overall Survival of Patients with Pancreatic Cancer through Multiagent Chemotherapy and Increased Rates of Surgical Resection

The American surgeon, 2023-12, Vol.89 (12), p.5964-5971

2023

Volltextzugriff (PDF)

Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2010-05, Vol.11 (3), p.198-203

2010

Volltextzugriff (PDF)

Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial

Clinical breast cancer, 2016-06, Vol.16 (3), p.180-187

2016

Volltextzugriff (PDF)

Identification of a Viability Domain in the Granulocyte/Macrophage Colony- Stimulating Factor Receptor β-Chain Involving Tyrosine-750

Proceedings of the National Academy of Sciences - PNAS, 1995-09, Vol.92 (19), p.8665-8669

1995

Volltextzugriff (PDF)

The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State

JCO precision oncology, 2023-05, Vol.7 (7), p.e2200619

2023

Volltextzugriff (PDF)

pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

Breast cancer research and treatment, 2010-09, Vol.123 (2), p.471-475

2010

Volltextzugriff (PDF)

JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region

Molecular and Cellular Biology, 1994-07, Vol.14 (7), p.4335-4341

1994

Volltextzugriff (PDF)

Sorafenib Plus Ixabepilone as First-Line Treatment for Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase 1/2 Trial

Clinical breast cancer, 2016

2016

Volltextzugriff (PDF)

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

Clinical breast cancer, 2010-10, Vol.10 (5), p.367-372

2010

Volltextzugriff (PDF)

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity

Blood, 1995-04, Vol.85 (7), p.1881-1887

1995

Volltextzugriff (PDF)

The Murine DUB-1 Gene Is Specifically Induced by the βc Subunit of the Interleukin-3 Receptor

Molecular and cellular biology, 1996-09, Vol.16 (9), p.4808-4817

1996

Volltextzugriff (PDF)

The Cytokine-Activated Tyrosine Kinase JAK2 Activates Raf-1 in a p21$^{\text{ras}}$-dependent Manner

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (21), p.11681-11686

1996

Volltextzugriff (PDF)

Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines

The Journal of immunology (1950), 1996-07, Vol.157 (2), p.534-540

1996

Volltextzugriff (PDF)

Pathway for Inositol 1,3,4-trisphosphate and 1,4-bisphosphate Metabolism

Proceedings of the National Academy of Sciences - PNAS, 1987-04, Vol.84 (8), p.2170-2174

1987

Volltextzugriff (PDF)

A low affinity chimeric human alpha/beta-granulocyte-macrophage colony-stimulating factor receptor induces ligand-dependent proliferation in a murine cell line

The Journal of biological chemistry, 1994-12, Vol.269 (48), p.30173-30180

1994

Volltextzugriff (PDF)

The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (21), p.11681-11686

1996

Volltextzugriff (PDF)

A Syndrome of Lymphoblastic Lymphoma, Eosinophilia, and MyeloidHyperplasia/Malignancy Associated With t(8; 13)(p11; q11): Description of aDistinctive Clinicopathologic Entity

Blood, 1995-04, Vol.85 (7), p.1881-1887

1995

Volltextzugriff (PDF)

Isolation and characterization of a partial cDNA clone for heparin cofactor II

Biochemical and biophysical research communications, 1986-05, Vol.137 (1), p.431-436

1986

Volltextzugriff (PDF)

Metabolism of inositol phosphates: Identification and characterization of inositol polyphosphate 1-phosphatase

Inhorn, Roger Charles

1990

Volltextzugriff (PDF)

JAK2 Associates with the βc Chain of the Receptor for Granulocyte-Macrophage Colony-Stimulating Factor, and Its Activation Requires the Membrane-Proximal Region

Molecular and cellular biology, 1994-07, Vol.14 (7), p.4335-4341

1994

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)
Dissertationen
(1)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)

Improved Overall Survival of Patients with Pancreatic Cancer through Multiagent Chemotherapy and Increased Rates of Surgical Resection

Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial

Identification of a Viability Domain in the Granulocyte/Macrophage Colony- Stimulating Factor Receptor β-Chain Involving Tyrosine-750

The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State

pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region

Sorafenib Plus Ixabepilone as First-Line Treatment for Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase 1/2 Trial

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity

The Murine DUB-1 Gene Is Specifically Induced by the βc Subunit of the Interleukin-3 Receptor

The Cytokine-Activated Tyrosine Kinase JAK2 Activates Raf-1 in a p21$^{\text{ras}}$-dependent Manner

Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines

Pathway for Inositol 1,3,4-trisphosphate and 1,4-bisphosphate Metabolism

A low affinity chimeric human alpha/beta-granulocyte-macrophage colony-stimulating factor receptor induces ligand-dependent proliferation in a murine cell line

The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner

A Syndrome of Lymphoblastic Lymphoma, Eosinophilia, and MyeloidHyperplasia/Malignancy Associated With t(8; 13)(p11; q11): Description of aDistinctive Clinicopathologic Entity

Isolation and characterization of a partial cDNA clone for heparin cofactor II

Metabolism of inositol phosphates: Identification and characterization of inositol polyphosphate 1-phosphatase

JAK2 Associates with the βc Chain of the Receptor for Granulocyte-Macrophage Colony-Stimulating Factor, and Its Activation Requires the Membrane-Proximal Region

Suchergebnisse filtern